FDA: Dollar Tree over-the-counter topicals may be adulterated

The U.S. Food and Drug Administration has sent a warning letter to Dollar Tree stores notifying the company that certain over-the-counter medications sourced from Shanghai and other international cities may be defective. The FDA detected flaws at several facilities between 2017 and 2019 and notified both the manufacturers and Dollar Tree that these products may

Johnson & Johnson loses Australian class action over pelvic mesh

For decades, one way doctors have treated organ prolapse is by surgically installing mesh implants into the pelvis to keep the prolapsing organ in the position where it is naturally supposed to be. Unfortunately, many women who have had pelvic mesh implants have experienced bleeding, chronic pain and severe pain during intercourse, and many have

Did Johnson & Johnson’s subsidiary market opioids deceptively?

In September, a judge in Oklahoma ruled that Johnson & Johnson’s subsidiary, Janssen Pharmaceuticals, caused a public nuisance with its two opioid medications, Duragesic and Nucynta. He also ruled that the company had marketed these drugs deceptively. The Judge ordered J&J and Janssen to pay $572 million in damages to the State. Since the Oklahoma

Jury imposes $8 billion punitive damages against J&J for Risperdal

Thousands of lawsuits involving the drug Risperdal have been filed against Johnson & Johnson and its subsidiary Janssen Pharmaceuticals, Inc. The main complaint by most of the young men suing is that taking Risperdal caused gynecomastia, or the abnormal development of breasts. Many plaintiffs were prescribed Risperdal as minors and none were told they might

Without admitting fault, J&J reaches opioid deal with 2 counties

According to the Centers for Disease Control and Prevention, Ohio had the second-highest rate of fatal opioid overdoses in the country in 2017. West Virginia led the nation in per capita opioid deaths. That’s part of the reason why Ohio is central to the National Prescription Opiate Litigation, where thousands of cases against opioid manufacturers

Without issuing recall, FDA advises Zantac users to switch drugs

**NO LONGER ACCEPTING NEW CASES   The heartburn medication ranitidine, brand-name Zantac, may contain low levels of a carcinogenic substance, according to recent information from the Food and Drug Administration. The agency has not ordered a recall, but it suggests people who take ranitidine contact their doctors about an alternative. Over-the-counter users should consider switching

Opioid manufacturers in settlement talks after J&J verdict

Recently, a judge in Oklahoma ruled that Johnson & Johnson created a public nuisance when it deceptively marketed its opioid painkillers Duragesic and Nucynta. He specifically stated that J&J had “caused an opioid crisis that is evidenced by increased rates of addiction, overdose deaths and neonatal abstinence syndrome in Oklahoma.” Attorneys for Oklahoma asked for

Skip to content